Quest Diagnostics Inc (NYSE:DGX)
$ 153.02 -0.4 (-0.26%) Market Cap: 17.08 Bil Enterprise Value: 23.40 Bil PE Ratio: 20.57 PB Ratio: 2.52 GF Score: 86/100

Quest Diagnostics Inc at Bank of America Global Research Healthcare Conference (Virtual) Transcript

May 11, 2021 / 04:30PM GMT
Release Date Price: $137.85 (-2.57%)
Derik De Bruin
BofA Securities, Research Division - MD of Equity Research

Hi, good afternoon, good morning, everybody. I'm Derik De Bruin, senior life sciences and diagnostic tools analyst for Bank of America. Welcome to our 2021 Virtual Viva Las Vegas Healthcare conference. Also with me from Bank of America is Ivy Ma who focuses on diagnostics companies also on the group. And so in diagnostics, we have Quest Diagnostics with us this morning for our next presenters. With us today is Mark Guinan, Executive Vice President and Chief Financial Officer; and Shawn Bevec, Head of IR. Gentlemen, welcome. Thanks for being here today.

Mark J. Guinan
Quest Diagnostics Incorporated - Executive VP & CFO

Thanks, Derik.

Shawn C. Bevec
Quest Diagnostics Incorporated - VP of Investor Relation

Thanks, Derik.

Questions & Answers

Derik De Bruin
BofA Securities, Research Division - MD of Equity Research

So, Mark, I want to start off with a big picture question just because

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot